PLGA nanoparticles co-loaded with resveratrol and doxycycline for dual-action periodontal therapy: in vitro and in vivo evaluation.
Periodontitis is a chronic inflammatory disease caused by a dysbiotic subgingival biofilm that triggers an imbalanced host immune response. This study developed and evaluated poly(lactic-co-glycolic acid) (PLGA) nanoparticles co-loaded with doxycycline (DOX) and resveratrol (RV) for dual-action periodontal therapy. Nan...